ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Total Intravenous Anesthesia (TIVA) Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-16W14226
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global Total Intravenous Anesthesia TIVA Market Research Report 2023
BUY CHAPTERS

Global Total Intravenous Anesthesia (TIVA) Market Research Report 2025

Code: QYRE-Auto-16W14226
Report
July 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
B. Braun Medical
Astrazeneca plc
Fresenius Kabi
AbbVie
Baxter Healthcare
Maruishi
Piramal
Hikma Pharmaceuticals
Mylan NV
Nhwa
Hengrui
Lunan

Total Intravenous Anesthesia (TIVA) Market

The global market for Total Intravenous Anesthesia (TIVA) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Total intravenous anaesthesia (TIVA) is a technique of general anaesthesia, which uses a combination of agents given exclusively by the intravenous route without the use of inhalation agents (Gas Anaesthesia).
North American market for Total Intravenous Anesthesia (TIVA) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Total Intravenous Anesthesia (TIVA) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Total Intravenous Anesthesia (TIVA) include B. Braun Medical, Astrazeneca, Fresenius-Kabi, AbbVie, Baxter Healthcare, Maruishi, Piramal, Hikma Pharmaceuticals, Mylan, Nhwa, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Total Intravenous Anesthesia (TIVA), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Total Intravenous Anesthesia (TIVA).
The Total Intravenous Anesthesia (TIVA) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Total Intravenous Anesthesia (TIVA) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Total Intravenous Anesthesia (TIVA) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Total Intravenous Anesthesia (TIVA) Market Report

Report Metric Details
Report Name Total Intravenous Anesthesia (TIVA) Market
Segment by Type
  • Propofol
  • Etomidate
  • Midazolam
  • Barbiturates
  • Others
Segment by Application
  • Predominantly Emergency
  • Orthopedic
  • Cosmetic Surgeries
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company B. Braun Medical, Astrazeneca, Fresenius-Kabi, AbbVie, Baxter Healthcare, Maruishi, Piramal, Hikma Pharmaceuticals, Mylan, Nhwa, Hengrui, Lunan
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Total Intravenous Anesthesia (TIVA) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Total Intravenous Anesthesia (TIVA) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Total Intravenous Anesthesia (TIVA) Market report?

Ans: The main players in the Total Intravenous Anesthesia (TIVA) Market are B. Braun Medical, Astrazeneca, Fresenius-Kabi, AbbVie, Baxter Healthcare, Maruishi, Piramal, Hikma Pharmaceuticals, Mylan, Nhwa, Hengrui, Lunan

What are the Application segmentation covered in the Total Intravenous Anesthesia (TIVA) Market report?

Ans: The Applications covered in the Total Intravenous Anesthesia (TIVA) Market report are Predominantly Emergency, Orthopedic, Cosmetic Surgeries, Others

What are the Type segmentation covered in the Total Intravenous Anesthesia (TIVA) Market report?

Ans: The Types covered in the Total Intravenous Anesthesia (TIVA) Market report are Propofol, Etomidate, Midazolam, Barbiturates, Others

1 Total Intravenous Anesthesia (TIVA) Market Overview
1.1 Product Definition
1.2 Total Intravenous Anesthesia (TIVA) by Type
1.2.1 Global Total Intravenous Anesthesia (TIVA) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Propofol
1.2.3 Etomidate
1.2.4 Midazolam
1.2.5 Barbiturates
1.2.6 Others
1.3 Total Intravenous Anesthesia (TIVA) by Application
1.3.1 Global Total Intravenous Anesthesia (TIVA) Market Value by Application (2024 VS 2031)
1.3.2 Predominantly Emergency
1.3.3 Orthopedic
1.3.4 Cosmetic Surgeries
1.3.5 Others
1.4 Global Total Intravenous Anesthesia (TIVA) Market Size Estimates and Forecasts
1.4.1 Global Total Intravenous Anesthesia (TIVA) Revenue 2020-2031
1.4.2 Global Total Intravenous Anesthesia (TIVA) Sales 2020-2031
1.4.3 Global Total Intravenous Anesthesia (TIVA) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Total Intravenous Anesthesia (TIVA) Market Competition by Manufacturers
2.1 Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Total Intravenous Anesthesia (TIVA) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Total Intravenous Anesthesia (TIVA), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Total Intravenous Anesthesia (TIVA), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Total Intravenous Anesthesia (TIVA), Product Type & Application
2.7 Global Key Manufacturers of Total Intravenous Anesthesia (TIVA), Date of Enter into This Industry
2.8 Global Total Intravenous Anesthesia (TIVA) Market Competitive Situation and Trends
2.8.1 Global Total Intravenous Anesthesia (TIVA) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Total Intravenous Anesthesia (TIVA) Players Market Share by Revenue
2.8.3 Global Total Intravenous Anesthesia (TIVA) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Total Intravenous Anesthesia (TIVA) Market Scenario by Region
3.1 Global Total Intravenous Anesthesia (TIVA) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Total Intravenous Anesthesia (TIVA) Sales by Region: 2020-2031
3.2.1 Global Total Intravenous Anesthesia (TIVA) Sales by Region: 2020-2025
3.2.2 Global Total Intravenous Anesthesia (TIVA) Sales by Region: 2026-2031
3.3 Global Total Intravenous Anesthesia (TIVA) Revenue by Region: 2020-2031
3.3.1 Global Total Intravenous Anesthesia (TIVA) Revenue by Region: 2020-2025
3.3.2 Global Total Intravenous Anesthesia (TIVA) Revenue by Region: 2026-2031
3.4 North America Total Intravenous Anesthesia (TIVA) Market Facts & Figures by Country
3.4.1 North America Total Intravenous Anesthesia (TIVA) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Total Intravenous Anesthesia (TIVA) Sales by Country (2020-2031)
3.4.3 North America Total Intravenous Anesthesia (TIVA) Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Total Intravenous Anesthesia (TIVA) Market Facts & Figures by Country
3.5.1 Europe Total Intravenous Anesthesia (TIVA) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Total Intravenous Anesthesia (TIVA) Sales by Country (2020-2031)
3.5.3 Europe Total Intravenous Anesthesia (TIVA) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Total Intravenous Anesthesia (TIVA) Market Facts & Figures by Region
3.6.1 Asia Pacific Total Intravenous Anesthesia (TIVA) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Total Intravenous Anesthesia (TIVA) Sales by Region (2020-2031)
3.6.3 Asia Pacific Total Intravenous Anesthesia (TIVA) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Total Intravenous Anesthesia (TIVA) Market Facts & Figures by Country
3.7.1 Latin America Total Intravenous Anesthesia (TIVA) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Total Intravenous Anesthesia (TIVA) Sales by Country (2020-2031)
3.7.3 Latin America Total Intravenous Anesthesia (TIVA) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Total Intravenous Anesthesia (TIVA) Market Facts & Figures by Country
3.8.1 Middle East and Africa Total Intravenous Anesthesia (TIVA) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Total Intravenous Anesthesia (TIVA) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Total Intravenous Anesthesia (TIVA) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Total Intravenous Anesthesia (TIVA) Sales by Type (2020-2031)
4.1.1 Global Total Intravenous Anesthesia (TIVA) Sales by Type (2020-2025)
4.1.2 Global Total Intravenous Anesthesia (TIVA) Sales by Type (2026-2031)
4.1.3 Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Type (2020-2031)
4.2 Global Total Intravenous Anesthesia (TIVA) Revenue by Type (2020-2031)
4.2.1 Global Total Intravenous Anesthesia (TIVA) Revenue by Type (2020-2025)
4.2.2 Global Total Intravenous Anesthesia (TIVA) Revenue by Type (2026-2031)
4.2.3 Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Type (2020-2031)
4.3 Global Total Intravenous Anesthesia (TIVA) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Total Intravenous Anesthesia (TIVA) Sales by Application (2020-2031)
5.1.1 Global Total Intravenous Anesthesia (TIVA) Sales by Application (2020-2025)
5.1.2 Global Total Intravenous Anesthesia (TIVA) Sales by Application (2026-2031)
5.1.3 Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Application (2020-2031)
5.2 Global Total Intravenous Anesthesia (TIVA) Revenue by Application (2020-2031)
5.2.1 Global Total Intravenous Anesthesia (TIVA) Revenue by Application (2020-2025)
5.2.2 Global Total Intravenous Anesthesia (TIVA) Revenue by Application (2026-2031)
5.2.3 Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Application (2020-2031)
5.3 Global Total Intravenous Anesthesia (TIVA) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 B. Braun Medical
6.1.1 B. Braun Medical Company Information
6.1.2 B. Braun Medical Description and Business Overview
6.1.3 B. Braun Medical Total Intravenous Anesthesia (TIVA) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 B. Braun Medical Total Intravenous Anesthesia (TIVA) Product Portfolio
6.1.5 B. Braun Medical Recent Developments/Updates
6.2 Astrazeneca
6.2.1 Astrazeneca Company Information
6.2.2 Astrazeneca Description and Business Overview
6.2.3 Astrazeneca Total Intravenous Anesthesia (TIVA) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Astrazeneca Total Intravenous Anesthesia (TIVA) Product Portfolio
6.2.5 Astrazeneca Recent Developments/Updates
6.3 Fresenius-Kabi
6.3.1 Fresenius-Kabi Company Information
6.3.2 Fresenius-Kabi Description and Business Overview
6.3.3 Fresenius-Kabi Total Intravenous Anesthesia (TIVA) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Fresenius-Kabi Total Intravenous Anesthesia (TIVA) Product Portfolio
6.3.5 Fresenius-Kabi Recent Developments/Updates
6.4 AbbVie
6.4.1 AbbVie Company Information
6.4.2 AbbVie Description and Business Overview
6.4.3 AbbVie Total Intravenous Anesthesia (TIVA) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 AbbVie Total Intravenous Anesthesia (TIVA) Product Portfolio
6.4.5 AbbVie Recent Developments/Updates
6.5 Baxter Healthcare
6.5.1 Baxter Healthcare Company Information
6.5.2 Baxter Healthcare Description and Business Overview
6.5.3 Baxter Healthcare Total Intravenous Anesthesia (TIVA) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Baxter Healthcare Total Intravenous Anesthesia (TIVA) Product Portfolio
6.5.5 Baxter Healthcare Recent Developments/Updates
6.6 Maruishi
6.6.1 Maruishi Company Information
6.6.2 Maruishi Description and Business Overview
6.6.3 Maruishi Total Intravenous Anesthesia (TIVA) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Maruishi Total Intravenous Anesthesia (TIVA) Product Portfolio
6.6.5 Maruishi Recent Developments/Updates
6.7 Piramal
6.7.1 Piramal Company Information
6.7.2 Piramal Description and Business Overview
6.7.3 Piramal Total Intravenous Anesthesia (TIVA) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Piramal Total Intravenous Anesthesia (TIVA) Product Portfolio
6.7.5 Piramal Recent Developments/Updates
6.8 Hikma Pharmaceuticals
6.8.1 Hikma Pharmaceuticals Company Information
6.8.2 Hikma Pharmaceuticals Description and Business Overview
6.8.3 Hikma Pharmaceuticals Total Intravenous Anesthesia (TIVA) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Hikma Pharmaceuticals Total Intravenous Anesthesia (TIVA) Product Portfolio
6.8.5 Hikma Pharmaceuticals Recent Developments/Updates
6.9 Mylan
6.9.1 Mylan Company Information
6.9.2 Mylan Description and Business Overview
6.9.3 Mylan Total Intravenous Anesthesia (TIVA) Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Mylan Total Intravenous Anesthesia (TIVA) Product Portfolio
6.9.5 Mylan Recent Developments/Updates
6.10 Nhwa
6.10.1 Nhwa Company Information
6.10.2 Nhwa Description and Business Overview
6.10.3 Nhwa Total Intravenous Anesthesia (TIVA) Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Nhwa Total Intravenous Anesthesia (TIVA) Product Portfolio
6.10.5 Nhwa Recent Developments/Updates
6.11 Hengrui
6.11.1 Hengrui Company Information
6.11.2 Hengrui Description and Business Overview
6.11.3 Hengrui Total Intravenous Anesthesia (TIVA) Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Hengrui Total Intravenous Anesthesia (TIVA) Product Portfolio
6.11.5 Hengrui Recent Developments/Updates
6.12 Lunan
6.12.1 Lunan Company Information
6.12.2 Lunan Description and Business Overview
6.12.3 Lunan Total Intravenous Anesthesia (TIVA) Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Lunan Total Intravenous Anesthesia (TIVA) Product Portfolio
6.12.5 Lunan Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Total Intravenous Anesthesia (TIVA) Industry Chain Analysis
7.2 Total Intravenous Anesthesia (TIVA) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Total Intravenous Anesthesia (TIVA) Production Mode & Process Analysis
7.4 Total Intravenous Anesthesia (TIVA) Sales and Marketing
7.4.1 Total Intravenous Anesthesia (TIVA) Sales Channels
7.4.2 Total Intravenous Anesthesia (TIVA) Distributors
7.5 Total Intravenous Anesthesia (TIVA) Customer Analysis
8 Total Intravenous Anesthesia (TIVA) Market Dynamics
8.1 Total Intravenous Anesthesia (TIVA) Industry Trends
8.2 Total Intravenous Anesthesia (TIVA) Market Drivers
8.3 Total Intravenous Anesthesia (TIVA) Market Challenges
8.4 Total Intravenous Anesthesia (TIVA) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
B. Braun Medical
Astrazeneca plc
Fresenius Kabi
AbbVie
Baxter Healthcare
Maruishi
Piramal
Hikma Pharmaceuticals
Mylan NV
Nhwa
Hengrui
Lunan
List of Tables
 Table 1. Global Total Intravenous Anesthesia (TIVA) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Total Intravenous Anesthesia (TIVA) Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Total Intravenous Anesthesia (TIVA) Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Total Intravenous Anesthesia (TIVA) Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Total Intravenous Anesthesia (TIVA) Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Total Intravenous Anesthesia (TIVA) Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Total Intravenous Anesthesia (TIVA) Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Total Intravenous Anesthesia (TIVA), Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Total Intravenous Anesthesia (TIVA), Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Total Intravenous Anesthesia (TIVA), Product Type & Application
 Table 12. Global Key Manufacturers of Total Intravenous Anesthesia (TIVA), Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Total Intravenous Anesthesia (TIVA) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Total Intravenous Anesthesia (TIVA) as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Total Intravenous Anesthesia (TIVA) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Total Intravenous Anesthesia (TIVA) Sales by Region (2020-2025) & (K Units)
 Table 18. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Region (2020-2025)
 Table 19. Global Total Intravenous Anesthesia (TIVA) Sales by Region (2026-2031) & (K Units)
 Table 20. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Region (2026-2031)
 Table 21. Global Total Intravenous Anesthesia (TIVA) Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Region (2020-2025)
 Table 23. Global Total Intravenous Anesthesia (TIVA) Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Region (2026-2031)
 Table 25. North America Total Intravenous Anesthesia (TIVA) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Total Intravenous Anesthesia (TIVA) Sales by Country (2020-2025) & (K Units)
 Table 27. North America Total Intravenous Anesthesia (TIVA) Sales by Country (2026-2031) & (K Units)
 Table 28. North America Total Intravenous Anesthesia (TIVA) Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Total Intravenous Anesthesia (TIVA) Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Total Intravenous Anesthesia (TIVA) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Total Intravenous Anesthesia (TIVA) Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Total Intravenous Anesthesia (TIVA) Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Total Intravenous Anesthesia (TIVA) Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Total Intravenous Anesthesia (TIVA) Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Total Intravenous Anesthesia (TIVA) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Total Intravenous Anesthesia (TIVA) Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Total Intravenous Anesthesia (TIVA) Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Total Intravenous Anesthesia (TIVA) Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Total Intravenous Anesthesia (TIVA) Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Total Intravenous Anesthesia (TIVA) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Total Intravenous Anesthesia (TIVA) Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Total Intravenous Anesthesia (TIVA) Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Total Intravenous Anesthesia (TIVA) Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Total Intravenous Anesthesia (TIVA) Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Total Intravenous Anesthesia (TIVA) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Total Intravenous Anesthesia (TIVA) Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Total Intravenous Anesthesia (TIVA) Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Total Intravenous Anesthesia (TIVA) Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Total Intravenous Anesthesia (TIVA) Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Total Intravenous Anesthesia (TIVA) Sales (K Units) by Type (2020-2025)
 Table 51. Global Total Intravenous Anesthesia (TIVA) Sales (K Units) by Type (2026-2031)
 Table 52. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Type (2020-2025)
 Table 53. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Type (2026-2031)
 Table 54. Global Total Intravenous Anesthesia (TIVA) Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Total Intravenous Anesthesia (TIVA) Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Type (2020-2025)
 Table 57. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Type (2026-2031)
 Table 58. Global Total Intravenous Anesthesia (TIVA) Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Total Intravenous Anesthesia (TIVA) Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Total Intravenous Anesthesia (TIVA) Sales (K Units) by Application (2020-2025)
 Table 61. Global Total Intravenous Anesthesia (TIVA) Sales (K Units) by Application (2026-2031)
 Table 62. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Application (2020-2025)
 Table 63. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Application (2026-2031)
 Table 64. Global Total Intravenous Anesthesia (TIVA) Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Total Intravenous Anesthesia (TIVA) Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Application (2020-2025)
 Table 67. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Application (2026-2031)
 Table 68. Global Total Intravenous Anesthesia (TIVA) Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Total Intravenous Anesthesia (TIVA) Price (US$/Unit) by Application (2026-2031)
 Table 70. B. Braun Medical Company Information
 Table 71. B. Braun Medical Description and Business Overview
 Table 72. B. Braun Medical Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. B. Braun Medical Total Intravenous Anesthesia (TIVA) Product
 Table 74. B. Braun Medical Recent Developments/Updates
 Table 75. Astrazeneca Company Information
 Table 76. Astrazeneca Description and Business Overview
 Table 77. Astrazeneca Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Astrazeneca Total Intravenous Anesthesia (TIVA) Product
 Table 79. Astrazeneca Recent Developments/Updates
 Table 80. Fresenius-Kabi Company Information
 Table 81. Fresenius-Kabi Description and Business Overview
 Table 82. Fresenius-Kabi Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Fresenius-Kabi Total Intravenous Anesthesia (TIVA) Product
 Table 84. Fresenius-Kabi Recent Developments/Updates
 Table 85. AbbVie Company Information
 Table 86. AbbVie Description and Business Overview
 Table 87. AbbVie Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. AbbVie Total Intravenous Anesthesia (TIVA) Product
 Table 89. AbbVie Recent Developments/Updates
 Table 90. Baxter Healthcare Company Information
 Table 91. Baxter Healthcare Description and Business Overview
 Table 92. Baxter Healthcare Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Baxter Healthcare Total Intravenous Anesthesia (TIVA) Product
 Table 94. Baxter Healthcare Recent Developments/Updates
 Table 95. Maruishi Company Information
 Table 96. Maruishi Description and Business Overview
 Table 97. Maruishi Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Maruishi Total Intravenous Anesthesia (TIVA) Product
 Table 99. Maruishi Recent Developments/Updates
 Table 100. Piramal Company Information
 Table 101. Piramal Description and Business Overview
 Table 102. Piramal Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Piramal Total Intravenous Anesthesia (TIVA) Product
 Table 104. Piramal Recent Developments/Updates
 Table 105. Hikma Pharmaceuticals Company Information
 Table 106. Hikma Pharmaceuticals Description and Business Overview
 Table 107. Hikma Pharmaceuticals Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Hikma Pharmaceuticals Total Intravenous Anesthesia (TIVA) Product
 Table 109. Hikma Pharmaceuticals Recent Developments/Updates
 Table 110. Mylan Company Information
 Table 111. Mylan Description and Business Overview
 Table 112. Mylan Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Mylan Total Intravenous Anesthesia (TIVA) Product
 Table 114. Mylan Recent Developments/Updates
 Table 115. Nhwa Company Information
 Table 116. Nhwa Description and Business Overview
 Table 117. Nhwa Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Nhwa Total Intravenous Anesthesia (TIVA) Product
 Table 119. Nhwa Recent Developments/Updates
 Table 120. Hengrui Company Information
 Table 121. Hengrui Description and Business Overview
 Table 122. Hengrui Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Hengrui Total Intravenous Anesthesia (TIVA) Product
 Table 124. Hengrui Recent Developments/Updates
 Table 125. Lunan Company Information
 Table 126. Lunan Description and Business Overview
 Table 127. Lunan Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Lunan Total Intravenous Anesthesia (TIVA) Product
 Table 129. Lunan Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Total Intravenous Anesthesia (TIVA) Distributors List
 Table 133. Total Intravenous Anesthesia (TIVA) Customers List
 Table 134. Total Intravenous Anesthesia (TIVA) Market Trends
 Table 135. Total Intravenous Anesthesia (TIVA) Market Drivers
 Table 136. Total Intravenous Anesthesia (TIVA) Market Challenges
 Table 137. Total Intravenous Anesthesia (TIVA) Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Total Intravenous Anesthesia (TIVA)
 Figure 2. Global Total Intravenous Anesthesia (TIVA) Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Total Intravenous Anesthesia (TIVA) Market Share by Type: 2024 & 2031
 Figure 4. Propofol Product Picture
 Figure 5. Etomidate Product Picture
 Figure 6. Midazolam Product Picture
 Figure 7. Barbiturates Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Total Intravenous Anesthesia (TIVA) Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Total Intravenous Anesthesia (TIVA) Market Share by Application: 2024 & 2031
 Figure 11. Predominantly Emergency
 Figure 12. Orthopedic
 Figure 13. Cosmetic Surgeries
 Figure 14. Others
 Figure 15. Global Total Intravenous Anesthesia (TIVA) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Total Intravenous Anesthesia (TIVA) Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Total Intravenous Anesthesia (TIVA) Sales (2020-2031) & (K Units)
 Figure 18. Global Total Intravenous Anesthesia (TIVA) Average Price (US$/Unit) & (2020-2031)
 Figure 19. Total Intravenous Anesthesia (TIVA) Report Years Considered
 Figure 20. Total Intravenous Anesthesia (TIVA) Sales Share by Manufacturers in 2024
 Figure 21. Global Total Intravenous Anesthesia (TIVA) Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Total Intravenous Anesthesia (TIVA) Players: Market Share by Revenue in Total Intravenous Anesthesia (TIVA) in 2024
 Figure 23. Total Intravenous Anesthesia (TIVA) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Total Intravenous Anesthesia (TIVA) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Total Intravenous Anesthesia (TIVA) Sales Market Share by Country (2020-2031)
 Figure 26. North America Total Intravenous Anesthesia (TIVA) Revenue Market Share by Country (2020-2031)
 Figure 27. United States Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Total Intravenous Anesthesia (TIVA) Sales Market Share by Country (2020-2031)
 Figure 30. Europe Total Intravenous Anesthesia (TIVA) Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Total Intravenous Anesthesia (TIVA) Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Total Intravenous Anesthesia (TIVA) Revenue Market Share by Region (2020-2031)
 Figure 38. China Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. China Taiwan Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Indonesia Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Thailand Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Malaysia Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Total Intravenous Anesthesia (TIVA) Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Total Intravenous Anesthesia (TIVA) Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Total Intravenous Anesthesia (TIVA) Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Total Intravenous Anesthesia (TIVA) Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. UAE Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Total Intravenous Anesthesia (TIVA) by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Total Intravenous Anesthesia (TIVA) by Type (2020-2031)
 Figure 59. Global Total Intravenous Anesthesia (TIVA) Price (US$/Unit) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Total Intravenous Anesthesia (TIVA) by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Total Intravenous Anesthesia (TIVA) by Application (2020-2031)
 Figure 62. Global Total Intravenous Anesthesia (TIVA) Price (US$/Unit) by Application (2020-2031)
 Figure 63. Total Intravenous Anesthesia (TIVA) Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Intravenous Injection General Anesthesia Drugs Market Insights Forecast to 2030
Totally Implantable Intravenous Device TIVAD Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Intravenous Anesthetic Market Research Report 2025
Global Intravenous Gemeral Anesthetics Drug Market Research Report 2024
Global Intravenous Anesthetics Market Research Report 2024
Global Inhalational Anesthesia Drugs Market Research Report 2024
Global Anaesthesia Vaporizer Market Research Report 2024
Global General Anesthesia Tracheal Intubation Kit Market Research Report 2024
Global Inhalational Anaesthesia Drugs Market Research Report 2024
Global Propofol Market Research Report 2025
Global Injection General Anesthetics Drug Market Research Report 2024
Global Propofol Anesthesia Drugs Market Research Report 2024
Injectable Anesthetics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Implantable Venous Access Port Market Insights Forecast to 2030
Global Alternate site Infusion Therapy Market Insights Forecast to 2030
Global Anesthesia Machines Market Research Report 2025
Global Intubation Cannula Market Insights Forecast to 2030
Global Inhalation General Anesthesia Drugs Market Research Report 2024
Global Anesthetic Market Insights Forecast to 2030
Global Surgical Intubation Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions